科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 未找到姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 未找到姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 未找到姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 未找到姓氏以该字母开头的医生 K
  12. 未找到姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 查找姓氏以该字母开头的医生 O
  16. 未找到姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 主动 查找姓氏以该字母开头的医生 S
  20. 未找到姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: S

  1. Dean A. Shumway, M.D.

    Dean A. Shumway, M.D.

    1. Radiation Oncologist
    1. Rochester, MN
    擅长领域:

    Proton therapy, Radiation therapy for breast cancer, Breast cancer

研究

放射治疗师与剂量师

妙佑医疗国际的医生和科学家致力于推进乳腺癌患者的放射治疗方案。该研究隶属于妙佑医疗国际综合癌症中心,包含女性癌症项目。此外,妙佑医疗国际是美国少数几家由国家癌症研究所资助的卓越研究专科项目(SPORE)乳腺癌研究医疗中心之一。

研究领域包括:

  • 研发减少正常组织暴露量的新方法,包括开创性的质子疗法技术
  • 开发创新放射治疗方案以减少治疗的副作用
  • 结合手术切除肿块和近距离治疗,安全地缩短治疗时间
  • 引领有望改善患者疗效的重要临床试验

了解更多关于在妙佑医疗国际的癌症研究的信息,包括乳腺癌治疗的新放射疗法的临床试验。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在乳腺癌领域的文献著述列表

Research Profiles

查看所有医生 • 所有位置

Oct. 23, 2024
  1. Bland KI, et al., eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. 5th ed. Elsevier; 2018. https://www.clinicalkey.com. Accessed Dec. 7, 2020.
  2. Tepper JE, et al. Breast cancer: Stages I-II. In: Gunderson & Tepper's Clinical Radiation Oncology. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Oct. 28, 2020.
  3. Taghian A. Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer. https://www.uptodate.com/contents/search. Accessed Dec. 6, 2020.
  4. Radiation therapy and you: Support for people with cancer. National Cancer Institute. https://www.cancer.gov/publications/patient-education/radiation-therapy-and-you. Accessed Dec. 6, 2020.
  5. Taghian A. Adjuvant radiation therapy for women with newly diagnosed, non-metastatic breast cancer. https://www.uptodate.com/contents/search. Accessed Dec. 6, 2020.
  6. Professions in radiation therapy. Radiologyinfo.org. https://www.radiologyinfo.org/en/info.cfm?pg=professions-radiation-therapy#part_2. Accessed Dec. 7, 2020.
  7. Office of Patient Education. Breast cancer guide. Mayo Clinic; 2017.
  8. Mutter RW (expert opinion). Mayo Clinic. Dec. 14, 2020.
  9. Breast SPOREs. National Cancer Institute. https://trp.cancer.gov/spores/breast.htm. Accessed Jan. 21, 2021.
  10. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Jan. 22, 2021.
  11. Sites. Translational Breast Cancer Research Consortium. http://pub.emmes.com/study/bcrc/sites/clinical_sites2.html. Accessed Jan. 22, 2021.
  12. Member institution lists. NRG Oncology. https://www.nrgoncology.org/About-Us/Membership/Member-Institution-Lists. Accessed Jan. 22, 2021.
  13. Hieken TJ, et al. A novel treatment schedule for rapid completion of surgery and radiation in early-stage breast cancer. Annals of Surgical Oncology. 2016; doi:10.1245/s10434-016-5321-1.
  14. Mutter RW, et al. Three fraction pencil-beam scanning proton accelerated partial breast irradiation: Early provider and patient reported outcomes of a novel regimen. Radiation Oncology. 2019; doi:10.1186/s13014-019-1417-7.
  15. Murray Brunt A, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicenter, non-inferiority, randomized, phase 3 trial. Lancet. 2020; doi:10.1016/S0140-6736(20)30932-6.
  16. Darby SC, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. The New England Journal of Medicine. 2013; doi:10.1056/NEJMoa1209825.
  17. Jethwa KR, et al. Three-fraction intracavitary accelerated partial breast brachytherapy: Early provider and patient-reported outcomes of a novel regimen. International Journal of Radiation Oncology-Biology-Physics. 2019; doi:10.1016/j.ijrobp.2018.12.025.